Viva Biotech Overview
- Year Founded
-
2008
- Status
-
Public
- Employees
-
2,077
- Stock Symbol
-
01873
- Investments
-
40
- Share Price
-
$0.08
- (As of Thursday Closing)
Viva Biotech General Information
Description
Viva Biotech Holdings is an integrated drug discovery platform. The company's operating segment includes Drug discovery services and Contract Development Manufacture Organisation (CDMO) and commercialisation services. It generates maximum revenue from the Contract Development Manufacture Organisation (CDMO) and commercialisation services segment. The Contract Development Manufacture Organisation (CDMO) and commercialisation services segment include contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates, and formulations. Geographically, the company generates a majority of its revenue from the United States of America, and the rest from the European Union, Chinese Mainland, Africa, and other regions.
Contact Information
Website
www.vivabiotech.comCorporate Office
- Number 735, Ziping Road
- Pudong New Area
- Shanghai, 201318
- China
Corporate Office
- Number 735, Ziping Road
- Pudong New Area
- Shanghai, 201318
- China
Viva Biotech Timeline
Viva Biotech Stock Performance
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.08 | $0.08 | $0.05 - $0.18 | $168M | 2.14B | 1.27M |
Viva Biotech Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 267,655 | 540,305 | 742,997 | 1,349,472 |
| Revenue | 277,252 | 304,681 | 353,347 | 325,857 |
| EBITDA | 54,742 | 42,636 | (17,491) | 101,809 |
| Net Income | (44) | (16,412) | (78,472) | 44,532 |
| Total Assets | 1,050,971 | 1,148,066 | 1,262,101 | |
| Total Debt | 0 | 268,490 | 409,163 | 416,482 |
Viva Biotech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Viva Biotech Comparisons
Industry
Financing
Details
00000
000000
Viva Biotech Competitors (2)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| 3Sbio | Formerly PE-Backed | Shenyang, China | 0000 | 00000 | 00000000 | 00000 |
| Asymchem | Formerly VC-backed | Tianjin, China | 0000 | 00000 | 000000000 |
Viva Biotech Patents
Viva Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20180079753-A1 | Inhibitors of cellular metabolic processes | Active | 22-Aug-2017 | 0000000000 | |
| US-10329298-B2 | Inhibitors of cellular metabolic processes | Inactive | 22-Aug-2017 | 0000000000 | 0 |
| US-20170159096-A1 | Method for fusion expression of ion channel protein and transport protein and protein fragment used therefor | Inactive | 05-Jun-2014 | 0000000000 | |
| US-20170137414-A1 | Compounds and their methods of use | Active | 21-Mar-2014 | 0000000000 | 0 |
| US-10000479-B2 | Compounds and their methods of use | Active | 21-Mar-2014 | C07D417/08 | 00 |
Viva Biotech Executive Team (8)
| Name | Title | Board Seat |
|---|---|---|
| Zheren Wang | Chief Financial Officer | |
| Xueheng Cheng | Chief Technology Officer | |
| Han Dai | Chief Innovation Officer and Head of Investment | |
| Cheney Mao | Founder, Chief Executive Officer, Chairman and Executive Director | |
| Yinghong Gao | Venture Partner |
Viva Biotech Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| Cheney Mao | Viva Biotech | Founder, Chief Executive Officer, Chairman and Executive Director | 000 0000 |
| Delin Ren | Self | Board Member | 000 0000 |
| Xiangrong Li | Self | Board Member | 000 0000 |
Viva Biotech Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Viva Biotech Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Viva Biotech Investments & Acquisitions (40)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Langhua Pharmaceutical | 21-Sep-2023 | 000000000 | 000.00 | BPO/Outsource Services | |
| Apeiron Biotechnology | 29-Mar-2022 | 00000 0000 | 000.00 | Drug Discovery | |
| BioCast Pharmaceutical | 29-Nov-2021 | 00000 0000 | BPO/Outsource Services | ||
| Full Circles Therapeutics | 01-Nov-2021 | 00000 0000 | Biotechnology | ||
| Telo Therapeutics | 21-Jun-2021 | Seed Round | 00.000 | Drug Discovery |
Viva Biotech Subsidiaries (2)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| SYNthesis Med Chem | Drug Discovery | Parkville, Australia | 2007 |
| Langhua Pharmaceutical | BPO/Outsource Services | Taizhou, China | 0000 |
Viva Biotech ESG
Risk Overview
Risk Rating
Updated November, 08, 2023
25.03 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
00.0
Management
Management is related to actions taken to manage ESG issues
00.00
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
00 of 16,009
Rank
Percentile
Pharmaceuticals
Industry
00 of 909
Rank
Percentile
Biotechnology
Subindustry
00 of 404
Rank
Percentile
Viva Biotech Exits (8)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| DTx Pharma | 21-Mar-2021 | 00000 00000 | 00000 | Completed |
|
| Focus-X Therapeutics | 10-Mar-2021 | 000000000000 | Completed |
|
|
| Totient | 03-Oct-2020 | 00000 00000 | 0000 | Completed |
|
| Tabomedex | 03-Aug-2020 | 00000 00000 | 000 | Completed |
|
| DTx Pharma | 06-Jan-2020 | Early Stage VC | 0000 | Completed |
|
Viva Biotech FAQs
-
When was Viva Biotech founded?
Viva Biotech was founded in 2008.
-
Who is the founder of Viva Biotech?
Cheney Mao is the founder of Viva Biotech.
-
Where is Viva Biotech headquartered?
Viva Biotech is headquartered in Shanghai, China.
-
What is the size of Viva Biotech?
Viva Biotech has 2,077 total employees.
-
What industry is Viva Biotech in?
Viva Biotech’s primary industry is Drug Discovery.
-
Is Viva Biotech a private or public company?
Viva Biotech is a Public company.
-
What is Viva Biotech’s stock symbol?
The ticker symbol for Viva Biotech is 01873.
-
What is the current stock price of Viva Biotech?
As of 19-Sep-2024 the stock price of Viva Biotech is $0.08.
-
What is the current market cap of Viva Biotech?
The current market capitalization of Viva Biotech is $168M.
-
What is Viva Biotech’s current revenue?
The trailing twelve month revenue for Viva Biotech is $277M.
-
Who are Viva Biotech’s competitors?
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
